OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 64 filers reported holding OVID THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $50,000 | -15.3% | 14,932 | -0.7% | 0.00% | – |
| Q2 2021 | $59,000 | -3.3% | 15,032 | -0.3% | 0.00% | – |
| Q1 2021 | $61,000 | +74.3% | 15,082 | +0.7% | 0.00% | – |
| Q4 2020 | $35,000 | -59.3% | 14,982 | 0.0% | 0.00% | – |
| Q3 2020 | $86,000 | -32.3% | 14,982 | -13.1% | 0.00% | – |
| Q2 2020 | $127,000 | +176.1% | 17,232 | +10.9% | 0.00% | – |
| Q1 2020 | $46,000 | -28.1% | 15,532 | 0.0% | 0.00% | – |
| Q4 2019 | $64,000 | +33.3% | 15,532 | +4.0% | 0.00% | – |
| Q3 2019 | $48,000 | +71.4% | 14,932 | 0.0% | 0.00% | – |
| Q2 2019 | $28,000 | +7.7% | 14,932 | 0.0% | 0.00% | – |
| Q1 2019 | $26,000 | -27.8% | 14,932 | 0.0% | 0.00% | – |
| Q4 2018 | $36,000 | -57.6% | 14,932 | 0.0% | 0.00% | – |
| Q3 2018 | $85,000 | -26.7% | 14,932 | 0.0% | 0.00% | – |
| Q2 2018 | $116,000 | +9.4% | 14,932 | 0.0% | 0.00% | – |
| Q1 2018 | $106,000 | – | 14,932 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,540,671 | $2,835,000 | 1.27% |
| Madison Avenue Partners, LP | 1,394,022 | $2,565,000 | 0.55% |
| BVF INC/IL | 6,851,051 | $12,606,000 | 0.52% |
| CHI Advisors LLC | 864,822 | $1,591,000 | 0.43% |
| Rubric Capital Management LP | 4,516,300 | $8,310,000 | 0.42% |
| EcoR1 Capital, LLC | 6,117,400 | $11,256,000 | 0.33% |
| Artal Group S.A. | 2,500,000 | $4,600,000 | 0.20% |
| DCF Advisers, LLC | 162,701 | $299,000 | 0.19% |
| Oasis Management Co Ltd. | 270,000 | $497,000 | 0.08% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 908,500 | $1,672,000 | 0.04% |